fluconazole has been researched along with osu 03012 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chabrier-Roselló, Y; DiDone, L; Gerik, KJ; Koselny, K; Krysan, DJ; Lodge, JK | 1 |
| Cushion, MT; DiDone, L; Fothergill, AW; Green, J; Halterman, JP; Koselny, K; Krysan, DJ; Patterson, TF; Rappelye, C; Wellington, M; Wiederhold, NP | 1 |
2 other study(ies) available for fluconazole and osu 03012
| Article | Year |
|---|---|
Cryptococcus neoformans phosphoinositide-dependent kinase 1 (PDK1) ortholog is required for stress tolerance and survival in murine phagocytes.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Antifungal Agents; Cell Wall; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Larva; Macrophages; Mice; Microbial Sensitivity Tests; Microbial Viability; Moths; Oxidative Stress; Phagocytosis; Protein Serine-Threonine Kinases; Pyrazoles; Reactive Oxygen Species; Stress, Physiological; Sulfonamides; Virulence | 2013 |
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.
Topics: Animals; Antifungal Agents; Candida; Caspofungin; Celecoxib; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Gene Expression Regulation, Fungal; Lipopeptides; Male; Mice, Inbred Strains; Microbial Sensitivity Tests; Pneumocystis; Pyrazoles; Saccharomyces cerevisiae; Sulfonamides | 2016 |